Crossmark

Efficacy and safety of a single dose of nirsevimab against respiratory syncytial virus infection in infants: a meta-analysis and time-to-event analysis

Crossref DOI link: https://doi.org/10.1186/s13052-025-02184-4

Published Online: 2025-12-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sayed, Mohamed Saad

Elgendy, Mena Ayman

Gamil, Nada

Abdullah, Hossam Hassan

Alhwary, Alaa

Ibrahim, Rahma Abdulfattah

Samir, Sama Hesham

Jibril, Nada S.

Abdulazeem, Hebatullah

Alsabri, Mohammed https://orcid.org/0000-0002-1410-7680
License Information

Text and Data Mining valid from 2025-12-30

Version of Record valid from 2026-01-30
More Information

Article History

Received: 5 September 2025

Accepted: 15 December 2025

First Online: 30 December 2025

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below